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Rod and cone phosphodiesterase 6 (PDE6) are key effector enzymes of the vertebrate
phototransduction pathway. Rod PDE6 consists of two catalytic subunits PDE6α and
PDE6β and two identical inhibitory PDE6γ subunits, while cone PDE6 is composed of
two identical PDE6α’ catalytic subunits and two identical cone-specific PDE6γ’ inhibitory
subunits. Despite their prominent function in regulating cGMP levels and therefore rod
and cone light response properties, it is not known how each subunit contributes to
the functional differences between rods and cones. In this study, we generated an
rd10/cpfl1 mouse model lacking rod PDE6β and cone PDE6α’ subunits. Both rod and
cone photoreceptor cells are degenerated with age and all PDE6 subunits degrade in
rd10/cpfl1 mice. We expressed cone PDE6α’ in both rods and cones of rd10/cpfl1 mice
by adeno-associated virus (AAV)-mediated delivery driven by the ubiquitous, constitutive
small chicken β-actin promoter. We show that expression of PDE6α’ rescues rod
function in rd10/cpfl1 mice, and the restoration of rod light sensitivity is attained through
restoration of endogenous rod PDE6γ and formation of a functional PDE6α’γ complex.
However, improved photopic cone responses were achieved only after supplementation
of both cone PDE6α’ and PDE6γ’ subunits but not by PDE6α’ treatment alone. We
observed a two fold increase of PDE6α’ levels in the eyes injected with both PDE6α’
plus PDE6γ’ relative to eyes receiving PDE6α’ alone. Despite the presence of both
PDE6γ’ and PDE6γ, the majority of PDE6α’ formed functional complexes with PDE6γ’,
suggesting that PDE6α’ has a higher association affinity for PDE6γ’ than for PDE6γ.
These results suggest that the presence of PDE6γ’ augments cone PDE6 assembly
and enhances its stability. Our finding has important implication for gene therapy of
PDE6α’-associated achromatopsia.
Keywords: phosphodiesterase 6 (PDE6), rd10, Cpfl1, adeno-associated viral vector (AAV), achromatopsia, gene
therapy, rod, cone
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INTRODUCTION
Cyclic nucleotide phosphodiesterases 6 (PDE6) belongs to the
highly conserved mammalian PDEs composed of 11 different
families that modulate cellular levels of the second messengers,
cAMP and cGMP, by controlling their rates of degradation
(Beavo, 1995; Francis et al., 2001). PDE6 is the key regulator of
cytoplasmic cGMP concentration in rod and cone photoreceptor
cells. Because of its primary role in controlling cGMP, regulation
of PDE6 is essential for the speed, sensitivity, recovery and
adaptation of visual signals (Burns and Arshavsky, 2005; Fu and
Yau, 2007). Rod PDE6 is composed of two catalytic subunits α
and β encoded by the PDE6A, PDE6B genes, and two inhibitory
subunits γ encoded by PDE6G. In contrast, cone PDE6 is
composed of two identical catalytic subunits of α’ encoded by
PDE6C and two cone-specific inhibitory subunits γ’ encoded by
PDE6H (Gillespie and Beavo, 1988; Hamilton and Hurley, 1990;
Li et al., 1990).
Despite the important role it plays in photoreceptor function,
the structure and function relationship of PDE6 is not well
understood due to failure of its functional expression in various
in vitro systems (Qin et al., 1992; Piriev et al., 1993, 2003; Qin
and Baehr, 1994). Electron microscopic analysis of purified rod
PDE6 catalytic dimers showed that the catalytic domains are
located at the C-terminus, and are highly conserved among all
known members of PDE family (Beavo, 1995). The N-terminal
domains of PDE6 catalytic subunits consist of two regulatory
cGMP binding GAF motifs (GAF A and GAF B) termed for their
presence in cGMP-regulated PDE, adenylyl cyclases and the E.
coli protein Fh1A (Aravind and Ponting, 1997). It is known that
there is a synergistic effect between PDE6γ and cGMP binding to
the catalytic subunits because: (1) PDE6γ binding to the catalytic
subunits enhances the affinity of cGMP for the noncatalytic sites;
and (2) when cGMP binds to the GAF domains, the affinity of
PDE6γ for the catalytic subunits increases (Cote et al., 1994;
Yamazaki et al., 2002). The region of PDE6γ responsible for
this effect has been mapped to the central polycationic domain
of PDE6γ known to have high affinity for the catalytic dimer
(Artemyev and Hamm, 1992; Mou and Cote, 2001). Functional
mapping of PDE6γ with the catalytic subunits showed that the
C-terminus of PDE6γ is a key inhibitory domain. It interacts
directly with the active site of PDE6 and blocks access of substrate
to the catalytic pocket and therefore controls cGMP hydrolysis
(Granovsky et al., 1997; Barren et al., 2009; Zhang and Artemyev,
2010). The middle region of PDE6γ stabilizes the overall binding
affinity of PDE6γ with the catalytic subunits (Zhang et al., 2012).
One unique feature of rod PDE6 among the PDE family
is that its catalytic subunits are composed of heterodimer αβ
subunits. Evidence suggests that PDE6γ may form structurally
and functionally distinctive interactions with the α- and β-
subunits, and this asymmetric binding of PDE6γ to PDE6αβ
may represent an important regulatory mechanism in rod
phototransduction (Guo et al., 2005, 2006). The molecular
mechanism underlying the distinctive photoresponses of rods
vs. cones is poorly understood and is one of the fundamental
questions remaining in photoreceptor biology. The potential
roles of rod and cone PDE6 in phototransduction is of particular
interest because PDE6’s functions in rods and cones as effector
enzymes in controlling cGMP levels in the outer segments is key
to fully understanding of rod and cone photoresponses. We have
shown previously that rods of rd10mice expressing cone PDE6α’
delivered by an adeno-associated virus (AAV) vector are more
sensitive to light than wild type rods, most likely due to the slower
shutoff of their light responses (Deng et al., 2013). A similar
study employing a transgenic approach showed that exchange
of cone PDE6α’ for rod PDEαβ partially mimics the features
of light adaptation (Majumder et al., 2015). Here, we study the
association affinities among different subunits of PDE6 following
AAV-mediated delivery in rd10/cpfl1 mice. The rd10/cpfl1 mice
carry mutations in both rod PDE6β and cone PDE6α’, and they
also lack rod PDE6αγ and cone PDE6γ’. We find that cone
PDE6α’ has an intrinsically higher affinity for its partner PDE6γ’
than for PDE6γ, and the presence of PDE6γ’ augments cone
PDE6 holoenzyme assembly and enhances its stability.
MATERIALS AND METHODS
Animals
Rd10, cpfl1, and wild-type C57BL/6J mice were obtained from
the Jackson Laboratory (Bar Harbor, ME, USA). Rd10 and cpfl1
mice were crossed to generate homozygous rd10/cpfl1 mutant
mice. Genotyping of rd10 and cpfl1 were performed according to
previously published methods (Chang et al., 2007; Kolandaivelu
et al., 2011). The mice were maintained in the University of
Florida Health Science Center Animal Care Services Facilities in
a continuously dark room, except for husbandry at ∼400 lux
illuminance. Physiological experiments were performed under
dim red illumination using a Kodak number 1 Safelight filter
(transmittance > 560 nm). All experiments were approved by
the local Institutional Animal Care and Use Committees at
the University of Florida and West Virginia University and
conducted in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research and NIH
regulations.
Construction and Packaging of AAV
Vectors
The murine PDE6γ’ cDNA was synthesized by GenScript
(Piscataway, NJ, USA) and subcloned under the ubiquitous,
constitutive small chicken β-actin promoter (smCBA; Haire
et al., 2006) in self-complimentary AAV vectors to create
sc-smCBA-mPDE6γ’. Construction of smCBA-mPDE6β and
smCBA-mPDE6α’ were described previously (Deng et al., 2013).
All constructs were packaged in AAV serotype 8-Y733F by
transfection of H293 cells according to previously published
methods (Zolotukhin et al., 1999).
Subretinal Injections
All vectors were adjusted to the same titer of 5 × 1012
vector genomes/ml before injection. One microliter of vector
was injected subretinally into the left eyes of rd10/cpfl1
pups at postnatal 14 (P14) while the right eyes served
as untreated controls. For co-injection, smCBA-mPDE6α’
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and sc-smCBA-mPDE6γ’ vectors were mixed at a 2:1 ratio
and 1 µl injected. Subretinal injections were performed as
previously described (Pang et al., 2006, 2008). Briefly, eyes
were dilated with 1% atropine (Akorn, Inc. Lake Forest,
IL, USA) and 2.5% phenylephrine hydrochloride solution
(Paragon Biotek, Portland, OR, USA). An aperture within the
pupil area was made through the cornea with a 30 gauge
disposable needle. A 33-gauge blunt needle mounted on a 5-
µl Hamilton syringe (Hamilton Co., Reno, NV, USA) was then
introduced through the corneal opening, avoiding the lens and
reaching the subretinal space. Injections were visualized by
fluorescein-positive subretinal bleb. 1% atropine eye drops and
neomycin/polymyxin B/dexamethasone ophthalmic ointment
(Bausch and Lomb Inc. Tampa, FL, USA) were given after
injection.
ERG Analysis
At 5 weeks post-injection, dark-adapted and light-adapted
electroretinograms (ERGs) were recorded separately using
a UTAS Visual Diagnostic System equipped with Big Shot
Ganzfeld (LKC Technologies, Gaithersburg, MD, USA)
according to protocols previously describe (Deng et al., 2013).
Scotopic rod recordings were performed with three increasing
light intensities at−1.6,−0.6, and 0.4 log cds/m2 after overnight
dark adaption. Ten responses were recorded and averaged at
each light intensity. Photopic cone recording were taken after
mice were adapted to a white background light of 30 cds/m2 for
10 min. Recordings were performed with four flash intensities
at 0.1, 0.7, 1.0 and 1.4 log cds/m2 in the presence of 30 cds/m2
background light. Fifty responses were recorded and averaged
at each intensity. Scotopic and photopic b-wave amplitudes
from untreated, treated rd10/cpfl1 and wild-type controls at
each intensity were averaged and used to generate a standard
deviation.
Immunohistochemistry and Morphology
Three days after ERG recordings, mice were sacrificed and eyes
were enucleated for immunohistochemical analysis. Eyes were
fixed in 4% paraformaldehyde at room temperature for 3 h.
Cornea, lens and vitreous were removed from eyes without
disturbing the retina. The remaining eyecup was rinsed with PBS
and then cryoprotected by immersion in 30% sucrose in PBS
for 4 h. Eyecups were then embedded in cryostat compound
(Tissue TEK OCT, Sakura Finetek USA, Inc., Torrance, CA,
USA) and frozen at −80◦C. Embedded eyecups were sectioned
at 12 µm thickness, rinsed in PBS, and blocked in 3% BSA,
0.3% Triton X-100 in PBS for 1 h at room temperature. Primary
antibodies were: PDE6α’ (3184P, A polyclonal antibody raised
in rabbit using purified His-tagged mouse PDE6α’ protein
(amino acids 1–115) as the immunogen, gift of Dr. Visvanathan
Ramamurthy, West Virginia University, Morgantown, WV,
USA, 3184P denotes the rabbit number used for raising cone
PDE6a’ antibody; Kirschman et al., 2010; Kolandaivelu et al.,
2011), rhodopsin, blue-cone opsin and red/green-cone opsin
(Millipore Bioscience Research Reagents). All primary antibodies
were diluted 1:1000 in 1% BSA in PBS and incubated with
sections overnight at 4◦C. The sections were then washed
three times with PBS, incubated with IgG secondary antibody
tagged with Alexa-594 (Invitrogen) at 1:500 dilution and Lectin
peanut agglutinin (PNA) conjugated to an Alexa Fluor 488
(Invitrogen) at 1: 200 dilution in PBS at room temperature for 1 h
and washed with PBS. Sections were mounted with Vectashield
Mounting Medium for Fluorescence (H-1000, Vector lab, In.
Burlingame, CA, USA) and coverslipped. Sections were analyzed
with a Zeiss CD25 microscope fitted with Axiovision Rel.
4.6 software.
For morphology analysis, eyecups were prepared as described
above, then paraffin-embedded and sectioned at 4 µm through
the optic nerve, followed by H&E staining.
Immunoprecipitation (IP)
PDE6 complexes and total protein density were analyzed by
immunoprecipitation (IP) with ROS-1 monoclonal antibody and
immunoblotting. The frozen eyecups (3 each) were homogenized
in 400 µl of IP buffer containing protease and phosphatase
inhibitors and 10 mM iodoacetamide (10 mM Tris-HCl, pH 7.5,
100 mM KCl, 20 mM NaCl, 1 mM MgCl2) using a pellet pestle
in a 1.5 ml Eppendorf tube on ice (5 s × 4). To solubilize the
proteins, Triton X-100 was added to a final concentration of 1%
and samples were incubated at 4◦C for 30 min. Supernatants
were collected by centrifuging at 10,000× g for 5 min at 4◦C
and incubated with 1.5 µg ROS-1 monoclonal antibody coupled
protein A/G beads for 3 h. Unbound proteins were removed
and beads were washed in wash buffer (1X PBS containing 0.1%
Triton X-100). PDE6 subunits bound to ROS-1 were eluted from
the beads by adding 1X SDS/PAGE sample buffer (62.5 mM
Tris, pH 6.8, 2% SDS, 10% glycerol, 0.005% bromophenol
blue, 5% 2-mercaptoethanol) and boiling for 5 min. Eluted
proteins were separated by 4%–20% SDS-polyacrylamide gel
(Bio-Rad) and immunoblotting was performed as described
earlier with catalytic and inhibitory subunits specific rod or
cone PDE6 antibodies (Kolandaivelu et al., 2011; Deng et al.,
2013). RetGC1 antibody was obtained from Dr. David Garbers
(Deceased, University of Southwestern Medical School, Dallas,
TX, USA). Membrane scanning and protein densities were
measured with an Odyssey Infrared Imaging System (LI-
COR Biosciences). Images are representative of at least three
independent experiments.
Statistical Analysis
Scotopic a- and b-wave and photopic b-wave amplitudes at
indicated flash intensities were compared by one-way ANOVA
with the post hoc Bonferroni test to compare means at
individual flash intensities. Protein quantifications were analyzed
by one-way ANOVA with Bonferroni post hoc test to compare
means of each treatment. Data were expressed as mean± SEM.
RESULTS
Histological Analysis of rd10/cpf1 Mouse
Retinas
We first compared rod photoreceptor cell degeneration in
rd10/cpfl1 mice to rd10 mice reared in the dark. Histological
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examination of hematoxylin and eosin (H&E) stained retinal
sections revealed progressive outer nuclear layer (ONL) thinning
in rd10/cpfl1 retinas mirroring the retinal degeneration seen in
rd10 mice (Figure 1A). Dark-reared rd10/cpfl1 mice showed
similar ONL as in the wild-type mice 2 weeks of age, however,
outer and inner segments appeared to be shorter. Retinal
degeneration was rapid with only half of ONL remaining at
4 weeks. By 8 weeks, only 2–3 layers of ONL were present.
We established that the rate of rod photoreceptor cell loss
in rd10/cpfl1 mouse is very similar to that of rd10 mice, as
previously reported (Chang et al., 2007).
We then characterized the rate of cone photoreceptor
cell degeneration by comparing the cone opsin
immunohistochemistry pattern in 2, 4 and 8 week-old rd10/cpfl1
and cpfl1 mice using a mixture of red/green- and blue-opsin
antibodies. One previous study showed that although cpfl1
retinas display grossly normal morphology and layering, there
is vacuolization of a small subset of cells in the photoreceptor
layer indicating cone loss as early as 3 weeks, with continued
cone degeneration and complete cone loss by 10 weeks of
age (Chang et al., 2009). Rd10/cpfl1 mice show a cone opsin
staining pattern similar to cpfl1 at 2 weeks of age, followed by
rapid cone photoreceptor cell degeneration with a majority
of cones absent by 4 weeks of age. By 8 weeks, cone opsin
staining was undetectable (Figure 1B). Cones of rd10/cpfl1 mice
degenerated slightly faster than those in cpfl1 mice most likely
due to concomitant rod degeneration. Furthermore, rd10/cpfl1
mice exhibited both flat scotopic and photopic ERG responses at
3 weeks of age (data not shown).
Rod and Cone Function in PDE6α’ and
PDE6α’+PDE6γ’-treated rd10/ cpfl1
Retinas
We first characterized the expression of cone PDE6α’ in
rd10/cpfl1mice treated with AAV8 Y733F-smCBA-PDE6α’. The
vector was subretinally delivered into one eye of postnatal 14
(P14) rd10/cpfl1 mice, while the contralateral eyes remained
untreated and served as controls. PDE6α’ expression was
analyzed by immunostaining at 5 weeks post-injection. In
C57BL/6 wild-type eyes, PDE6α’ is expressed specifically in
cones (Figure 2). Untreated rd10/cpfl1 eyes showed no PDE6α’
expression, whereas injected eyes showed robust PDE6α’
expression in both rods and cones.
We next characterized the rod function in PDE6α’- and
PDE6α’+PDE6γ’-treated rd10/cpfl1 eyes by full-field ERG
analysis. Expression of PDE6α’ or PDE6α’+PDE6γ’ driven by
smCBA promoter led to significant restoration of scotopic
ERG responses at 5 weeks post-injection (Figures 3A–C). Both
average b-wave and a-wave amplitudes in treated eyes are
significantly higher than their undetectable ERG responses in
contralateral untreated eyes at three light intensities tested. The
average rod-mediated b-wave amplitude at a flash intensity of
−1.6 log cds m−2 was 166 ± 14 µV (mean ± SEM) in PDE6α’-
treated eyes, significantly higher than untreated controls (n = 6,
P < 0.001, F = 253.0), and approximately 50% of those in the
wild-type controls. The average rod-mediated a-wave amplitude
at a flash intensity of −1.6 log cds m−2 was 21 ± 4.9 µV in
PDE6α’-treated eyes, significantly higher than untreated controls
(n = 6, P < 0.01, F = 28.34). Measured rod ERG responses were
similar in eyes receiving PDE6α’ alone or PDE6α’ and PDE6γ’
mixture (n = 6, P > 0.05).
Rescue of rod photoreceptor cells in PDE6α’-treated eyes
was also confirmed by examination of retinal morphology
and immunostaining for rhodopsin. Hematoxylin and eosin
staining (H&E) showed partial retinal structure preservation in
treated eyes with 7–8 layers of photoreceptor nuclei retained
in the ONL, while only one layer remained in contralateral
untreated eyes. Retinal outer segments were also preserved in
treated eyes (Supplementary Figure S1A). Consistent with this
result, immunostaining with a rhodopsin antibody showedmuch
stronger rhodopsin expression in treated eyes compared to
almost undetectable staining in untreated eyes (Supplementary
Figure S1B).
In contrast to robust rod rescue in rd10/cpfl1 mice by
PDEα’, rescue of cone function was significantly muted in
PDE6α’-treated eyes (Figures 3D,E). To test the hypothesis
that the presence of PDE6γ’ might assist proper folding
of cone PDE6 holoenzyme and improve cone ERG rescue,
PDE6γ’ driven by a smCBA promoter packaged in a fast-acting
self-complimentary AAV vector was co-injected with PDE6α’.
Improved photopic ERG responses were obtained with an
average cone b-wave amplitude of 38 ± 1.5 µV (n = 6) at
1.4 log cds m−2, which was significantly higher than amplitudes
from eyes treated with PDE6α’ alone (12 ± 1.9 µV, P < 0.001,
F = 580.4). Immunostaining with M/S-opsin antibodies and
PNA in co-injected eyes showed cone morphology rescue
(Supplementary Figure S1C). Mild cone morphology rescue was
also observed in PDE6α’-treated eyes (data not shown), however,
these cones mostly existed because of slower degeneration due to
rescue of rods. Our results suggest that the presence of PDE6γ’
from an earlier onset expression vector may help the proper
folding, assembly, and stabilization of PDE6α’ more efficiently.
The stability of the PDE6 α’γ’ complex could be vital for
enhancing the survival and function of cones.
Presence of PDE6γ’ Augments Cone
PDE6 Assembly and Stability
Rd10/cpfl1 mice carry mutations in both rod PDE6β and cone
PDE6α’. Next we investigated the levels of PDE6α’, PDE6γ’
and PDE6γ subunits by Western blot analysis from retinal
extracts of C57Bl/6 wild-type control, uninjected rd10/cpfl1, and
rd10/cpfl1 injected with PDE6β, PDE6α’, or PDE6α’+PDE6γ’.
We took advantage of the fact that cone specific PDE6γ’ has a
slightly higher molecular weight than rod PDE6γ (Gillespie and
Beavo, 1988) and used the same antibody to distinguish them.
Western blot analysis showed that untreated rd10/cpfl1 eyes
lacked all three rod PDE6 subunits (Figure 4A; Supplementary
Figure S2), and PDE6α’ treatment restored expression of rod
PDE6γ subunits, similar to eyes treated with rod PDE6β
(Figure 4A). However, cone PDE6γ’ expression was not detected
in PDE6α’-treated eyes. In contrast, rd10/cpfl1 eyes co-injected
with PDE6α’+PDE6γ’ showed significantly higher levels of
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FIGURE 1 | Histological analysis of rd10/cpf1 mouse retinas. (A) Comparison of morphology of rd10/cpfl1 to rd10 by H&E staining. Rod photoreceptor cells
degenerate with age as shown by thinning of ONL and loss of photoreceptor outer and inner segments. (B) Comparison of cone photoreceptor cell degeneration in
rd10/cpfl1 with cpfl1 by anti-cone opsin antibody staining (labeled as red). OS/IS, outer/inner segments; ONL, outer nuclear layer; INL, inner nuclear layer; GCL,
ganglion cell layer. Scale bar: 20 µm.
expression of both PDE6α’ and PDE6γ’ (Figure 4A). Qualitative
analysis of the amount of PDE6α’, PDE6γ and PDE6γ’ from these
samples showed that PDE6α’ levels were approximately double
in co-injected eyes compared to eyes receiving only PDE6α’
(Figure 4B, top panel, N = 3, P < 0.005). The levels of PDE6γ
in PDEβ- and PDE6α’-treated eyes were similar (N = 3, P > 0.05)
and were about half of that in the wild-type control (N = 3,
P < 0.001). However, the levels of PDE6γ were reduced (N = 3,
P < 0.05) while the amount of PDE6γ’ was about twice as much
as PDE6γ in co-injected eyes (Figure 4B, bottom panel). PDE6γ’
is delivered in half of the vector genomes of PDE6α’ (vector
genome ratio 1:2). PDE6γ’ expression is expected to occur in both
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FIGURE 2 | Detection of phosphodiesterase 6 (PDE6)α’ expression by immunofluorescence in rd10/cpfl1 retinas following delivery of adeno-associated virus
(AAV)-smCBA-PDE6α’. No PDE6α’ expression is detected in untreated eyes (left panel), while PDE6α’ (labeled as red) was expressed in both rods and cones in
treated eyes (middle panel). PDE6α’ is expressed exclusively in cones in wild type mice (right panel). Cones were labeled by peanut agglutinin (PNA) as green. Note
the much thicker ONL in the treated retina compared to that in the untreated control. Scale bar, 20 µm.
rods and cones following AAV vector delivery because we are
using the nonspecific, ubiquitous smCBA promoter. However,
we do not have a PDE6γ’-specific antibody to demonstrate this by
immunohistochemistry. The higher PDE6α’ levels in co-injected
eyes is mostly likely due to the presence of PDE6γ’.
Finally, we investigated the assembly status of PDE6 from
the above samples by IP using ROS-I, a mouse monoclonal
antibody that exclusively recognizes assembled and functional
PDE6 complexes in both rods and cones (Kolandaivelu et al.,
2009, 2011). We have shown previously that restoration of light
sensitivity by cone PDE6α’ in rods of rd10 mice was attributed
to functional complex formation between cone PDE6α’ and rod
PDE6γ (Deng et al., 2013). Here we confirm that rescue of rod
function by PDE6α’ in rd10/cpfl1mice is also due to stabilization
of endogenous PDE6γ and the resultant functional complex
formation of PDE6α’γ (Figure 4C, Supplementary Figure S2).
Interestingly, in PDE6α’+PDE6γ’ co-injected eyes, the majority
of PDE6α’ coupled with PDE6γ’, with only a small amount
of PDE6α’ associated with rod PDE6γ (Figure 4C), although
PDE6γ was restored due to presence of PDE6α’. These results
suggest that the reduced level of PDE6γ in co-injected eyes
might be the result of degradation due to its reduced coupling
to PDE6α’. Overall, these results clearly demonstrate that
cone PDE6γ’ delivered with PDE6α’ specifically enhances cone
PDE6 assembly and its stability, while assembly of endogenous
rod PDE6γ with PDE6α’ is severely reduced in presence of
PDE6γ’.
DISCUSSION
We studied the association among PDE6 subunits in vivo using
rd10/cpfl1 mice. The rd10/cpfl1 mice have no detectable rod and
cone ERG function, and carry mutations in both rod PDE6β and
cone PDE6α’. Interestingly, these mice also lack rod PDE6αγ
and cone PDE6γ’.The loss of both rod and cone PDE6 in these
mice lead to early onset and rapid rod and cone photoreceptor
cell degeneration. We show here that AAV vector-mediated
expression of cone PDE6α’ driven by a constitutive promoter can
rescue rod-mediated light responses and this functional rescue
is achieved through stabilization of endogenous rod PDE6γ and
complex formation of PDE6α’γ. However, improved photopic
ERG responses were attained only in eyes co-injected with
vectors expressing both PDE6α’ and PDE6γ’, but not in the eyes
injected with the PDE6α’ vector alone. The levels of PDE6α’
are significantly higher in co-injected eyes and the majority
of PDE6α’ complexed with PDE6γ’, although PDE6γ is also
detected. These results demonstrate that PDE6α’ has higher
intrinsic affinity for PDE6γ’ and its presence facilitates cone
holoenzyme assembly and augmented its stability.
One of the biggest challenges hampering PDE6 research
is failure of functional expression of this enzyme in various
in vitro systems. It was recently shown that AIPL1 is an
obligate chaperone required for heterologous expression of
active PDE6α’ in cultured cells, and that the presence of
PDE6γ dramatically increases the proportion of correctly
folded, functional PDE6 produced in the presence of AIPL1
(Gopalakrishna et al., 2016). Our results showing that the
presence of PDE6γ’ helps to stabilize cone PDE6 holoenzyme is
consistent with this observation. In our experiment, we also find
that PDE6γ’ increases the stability of PDE6α’ and facilitates cone
PDE6 assembly demonstrated by the significant elevated amount
of PDE6α’ as well as assembled and functional cone PDE6. We
also found that levels of PDE6γ is reduced in co-injected eyes
compared to eyes received PDE6α’ alone. We speculate that this
reduction is the result of degradation due to its reduced coupling
to PDE6α’ when PDE6γ’ is present. This is supported by previous
studies suggesting that stability of PDE6 complex is dependent
on the association of its interacting partners. First, in rd10 mice
carrying a mutation of PDE6β, PDE6α and PDE6γ were not
detected (Deng et al., 2013). Second, AIPL1 interacts with PDE6α
and the interaction is essential for PDE6 assembly. In the absence
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FIGURE 3 | Scotopic and photopic electroretinogram (ERG) responses in rd10/cpfl1 mice treated with PDE6α’ alone or PDE6α’ and PDE6γ’ together.
(A) Representative examples of dark-adapted ERG traces from rd10/cpfl1 mice at 5 weeks following delivery of AAV-smCBA-PDE6α’. (B) Dark-adapted b-wave is
partially restored in injected rd10/cpfl1 eyes. One-way ANOVA with the post hoc Bonferroni test demonstrated a significant difference between uninjected and
contralateral vector-treated eyes at light intensities of −1.6, −0.6 and 0.4 log cds/m2 (data shown are mean ± SEM, N = 6, ∗p < 0.001 at all three light intensities,
F = 253.0, 134.6 and 212.9 at −1.6, −0.6 and 0.4 log cds/m2, respectively). (C) Dark-adapted a-wave is partially restored in injected rd10/cpfl1 eyes. One-way
ANOVA with the post hoc Bonferroni test demonstrated a significant difference between uninjected and contralateral vector-treated eyes (mean ± SEM, N = 6,
∗p < 0.01 at all three light intensities, F = 28.34, 20.98 and 63.20 at −1.6, −0.6 and 0.4 log cds/m2, respectively). (D) Representative examples of full-field
light-adapted ERG traces from rd10/cpfl1 mice at 5 weeks following delivery of AAV-smCBA-PDE6α’ alone or co-injection of AAV-smCBA-PDE6α’ and
scAAV-smCBA-PDE6γ’. (E) Photopic b-wave amplitudes are significantly higher in PDE6α’+γ’ co-injected eyes than eyes receiving PDE6α’ alone. The bar graph
shows averaged ERG responses from 6 mice at a light intensity of 1.4 log cds/m2 (data shown are mean ± SEM, N = 6, ∗p < 0.01, F = 580.4).
of AIPL1, all PDE6 subunits are degraded regardless of their
normal synthesis (Kolandaivelu et al., 2009). Therefore, our data
support the same conclusion that PDE6γ’ potentiates the proper
folding of PDE6α’ and plays a critical role in the maturation of
cone PDE6 holoenzyme.
An interesting question raised by this study is why PDE6γ’
enhances cone PDE6 assembly and stability compared with rod
PDE6γ? A previous study demonstrated that the rod PDE6γ
naturally exists in mouse cones and can couple with cone PDE6α’
to protect cone function and stability (Brennenstuhl et al., 2015).
Our data show that the PDE6α’ can couple with PDE6γ when
PDE6γ’ is absent. However, when PDE6γ’ is present along with
the endogenous PDE6γ, PDE6α’ has a higher association affinity
for its natural partner. Such a higher affinity might play a role
in the faster light response kinetics of cone photoreceptor cells.
Although the overall three-dimensional structure of the rod
PDE6 holoenzyme was defined by using negative-stain electron
microscopy, the quaternary structure of PDE6αβ as well as the
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FIGURE 4 | Cone PDE6 assembly and stability is enhanced when PDE6α’ and PDE6γ’ are co-expressed. (A) Immunoblotting of retinal extracts from wild type
control, uninjected rd10/cpfl1, rd10/cpfl1 mice injected with PDE6β, PDE6α’ and PDE6α’+PDE6γ’, and analyzed with the indicated antibodies. (B) Quantification of
cone PDE6α’, rod PDE6γ and cone PDE6γ’ levels in retinal extracts from samples in (A). Band densities were measured with a Li-COR Odyssey image analyzer.
Statistical analysis show that PDE6α’ is significantly higher in PDE6α’+PDE6γ’-treated eyes than eyes treated with PDE6α’ alone (top panel, mean ± SEM, N = 3,
∗p < 0.005), whereas PDE6γ is reduced in PDE6α’+PDE6γ’-treated compared to eyes treated with PDE6α’ alone (bottom panel, mean ± SEM, N = 3, ∗p < 0.05,
F = 53.44). There is no significant difference of PDE6γ levels between PDE6β- and PDE6α’-treated eyes (N = 3, p > 0.05). (C) Immunoblots show the assembled rod
PDE6 and cone PDE6 when probed with ROS mouse monoclonal antibody from retinal extracts of wild type controls, uninjected rd10/cpfl1, and rd10/cpfl1 mice
injected with PDE6β, PDE6α’, and PDE6α’+PDE6γ’. Immunoblots were probed with indicated antibodies. Immunoprecipitation (IP) samples are 10 times more
concentrated than input fractions. Protein molecular weight markers are shown on the left. T, Total; U, Unbound and E, Elution.
interface between PDE6αβ and their inhibitory subunits PDE6γ
remains elusive (Kameni Tcheudji et al., 2001; Goc et al., 2010).
In addition, the heterogeneity of the rod PDE6α and β catalytic
subunits in terms of their interactions with PDE6γ is poorly
understood. There is evidence that PDE6γ may form distinctive
structural and functional interactions with the PDE6α and PDEβ
subunits (Guo et al., 2005). Despite the fact that rod and cone
PDE6 subunits share similar domain organizations, the detailed
structural relationships between PDE6α’ and γ’ is unknown and
cone PDE6may have a differentmode of regulation and therefore
display different enzymatic kinetics. Single cell recordings from
rods expressing PDE6α’γ and PDE6α’γ’ would give detailed
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information regarding light signaling properties between the two
types of rods and might reveal if PDE6γ’ plays a role in the
faster light response of cones. The ideal model to perform this
experiment would be a knock-in mouse line with endogenous
PDE6γ replaced with cone PDE6γ’. In these mice, PDE6γ’ is
expressed at the same level as PDE6γ in wild type mice, therefore
detailed light response kinetics can be compared. Single cell
recordings were not performed here due to the stochastic nature
of AAV vector expression.
In our previous study, we showed that rod visual performance
measured by optomotor responses was significantly improved in
rd10mice treated with PDE6α’ but remained subpar compared to
wild-type controls (Deng et al., 2013). We would expect similar
improvement of scotopic visual acuity in rd10/cpfl1mice treated
with PDE6α’ alone or a PDE6α’γ’ mixture. We also note that
although improved photopic ERG responses were obtained with
co-injection of vectors expressing both PDE6α’ and PDE6γ’,
there is a possibility that these photopic recordings were
partially derived from rods expressing cone PDE6α’γ’. These rods
might be desensitized and could not be saturated by standard
scotopic conditions, although our photopic ERG recordings were
performed after longer than standard light exposure time for
saturating normal rods. One approach to address this issue would
be to express PDE6γ’ under a cone-specific promoter instead
of a constitutive promoter such as CBA. However, our best
cone-preferred promoter still confers some level of expression in
the mouse rods (Dyka et al., 2014).
In summary, we show that cone PDE6α’ has an intrinsically
higher affinity for its partner PDE6γ’ than for rod PDE6γ
and that the presence of PDE6γ’ helps to stabilize cone PDE6
holo-enzyme and augment its assembly. This finding might be
important for designing future gene therapy studies for treating
patients with PDE6α’-associated achromatopsia.
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